mianserin has been researched along with Heart Failure in 5 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Notably, noradrenergic and specific serotonergic antidepressant (mirtazapine) use was significantly associated with higher prevalence of heart failure (OR 3." | 3.79 | Association of antidepressant and atypical antipsychotic use with cardiovascular events and mortality in a veteran population. ( Acharya, S; Acharya, T; Huang, J; Tringali, S, 2013) |
| "Two patients, who were receiving therapy with mianserin for depressive disorders, developed signs of disturbed cardiac function which resolved after mianserin therapy was discontinued." | 3.67 | Disturbed cardiac function possibly associated with mianserin therapy. ( Evans, L; Klug, P; Whiteford, H, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loyaga-Rendon, RY | 1 |
| Taylor, DO | 1 |
| Koval, CE | 1 |
| Acharya, T | 1 |
| Acharya, S | 1 |
| Tringali, S | 1 |
| Huang, J | 1 |
| Whiteford, H | 1 |
| Klug, P | 1 |
| Evans, L | 1 |
| Tulloch, AE | 1 |
| Shaw, WL | 1 |
5 other studies available for mianserin and Heart Failure
| Article | Year |
|---|---|
Progressive multifocal leukoencephalopathy in a heart transplant recipient following rituximab therapy for antibody-mediated rejection.
Topics: Antibodies, Monoclonal, Murine-Derived; Cognition Disorders; Fatal Outcome; Graft Rejection; Heart F | 2013 |
Association of antidepressant and atypical antipsychotic use with cardiovascular events and mortality in a veteran population.
Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Cardiovascular Diseases; Cross-Sectional S | 2013 |
Disturbed cardiac function possibly associated with mianserin therapy.
Topics: Aged; Atrial Fibrillation; Depressive Disorder; Dibenzazepines; Female; Heart Failure; Humans; Hypok | 1984 |
Two clinical syndromes and mianserin.
Topics: Adult; Antidepressive Agents, Tricyclic; Dibenzazepines; Dothiepin; Drug Synergism; Female; Heart Fa | 1978 |
Mianserin.
Topics: Dibenzazepines; Heart Failure; Humans; Mianserin; Unconsciousness | 1978 |